Processes for the preparation of Veliparib and intermediates thereof

US10556887B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10556887-B2
Application numberUS-201816167882-A
CountryUS
Kind codeB2
Filing dateOct 23, 2018
Priority dateOct 24, 2017
Publication dateFeb 11, 2020
Grant dateFeb 11, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides processes for the preparation of Veliparib (1), as well as intermediates useful in the preparation thereof. In particular, processes are provided for the production of the compound of Formula (3), or a salt thereof, and cyclization to afford Veliparib (1).

First claim

Opening claim text (preview).

What is claimed is: 1. A process for preparing Veliparib (1): or a salt thereof, comprising (i) cyclizing, in the presence of an acid (A1), a compound of Formula (3): wherein G is CONH 2 or R; R is CO 2 R 1 or CN; and R 1 is selected from the group consisting of H, an aliphatic group, a substituted aliphatic group, aryl, substituted aryl, arylalkyl and substituted arylalkyl; to provide either Veliparib (1) when G is CONH 2 , or, when G is R, a compound of Formula (2):  and wherein R is CO 2 R 1 or CN; and R 1 is selected from the group consisting of H, an aliphatic group, a substituted aliphatic group, aryl, substituted aryl, arylalkyl and substituted arylalkyl; and (ii) when G is R, converting the compound of Formula (2) to Veliparib (1). 2. The process of claim 1 , wherein G is CONH 2 . 3. The process of claim 1 , wherein G is R, R is CO 2 R 1 , and R 1 is H. 4. The process of claim 1 , wherein G is R, R is CO 2 R 1 , and R 1 is an aliphatic group. 5. The process of claim 4 , wherein R 1 is C1-C6 alkyl. 6. The process of claim 5 , wherein R 1 is methyl. 7. The process of claim 6 , wherein in step (ii), converting of the compound of Formula (2) to Veliparib (1) comprises treating the compound of Formula (2) with a source of ammonia. 8. The process of claim 7 , wherein the source of ammonia is selected from the group consisting of ammonia gas, ammonium hydroxide and a solution of ammonia in methanol solvent. 9. The process of claim 1 , wherein acid (A1) is a substantially anhydrous acid selected from the group consisting of carboxylic acids, sulfonic acids and mineral acids. 10. The process of claim 9 , wherein acid (A1) is acetic acid. 11. The process of claim 10 , wherein G in the compound of Formula (3) is CONH 2 , and Veliparib (1) is provided as a diacetic acid salt. 12. A process for the preparing a compound of Formula (3): or a salt thereof, wherein G is CONH 2 or R; R is CO 2 R 1 or CN; and R 1 is selected from the group consisting of H, an aliphatic group, a substituted aliphatic group, aryl, substituted aryl, arylalkyl and substituted arylalkyl; comprising coupling, in the presence of a solvent (S2), of the compound of Formula (5): with a compound of Formula (4): or a salt thereof, wherein G is CONH 2 or R; R is CO 2 R 1 or CN; and R 1 is selected from the group consisting of H, an aliphatic group, a substituted aliphatic group, aryl, substituted aryl, arylalkyl and substituted arylalkyl. 13. The process of claim 12 , wherein G is CONH 2 . 14. The process of claim 13 , wherein solvent (S2) is selected from the group consisting of 1,4-dioxane, tetrahydrofuran, N,N-dimethylformamide and N-methyl-2-pyrrolidone. 15. The process of claim 13 , wherein the coupling is conducted at a temperature of at least about 50° C. 16. The process of claim 13 , wherein the coupling is conducted in the presence of a base (B2-B) that is selected from the group consisting of 4-(dimethylamino)pyridine and 1-methylimidazole. 17. A compound of Formula (3): or a salt thereof, wherein G is CONH 2 or R; R is CO 2 R 1 or CN; and R 1 is selected from the group consisting of H, an aliphatic group, a substituted aliphatic group, aryl, substituted aryl, arylalkyl and substituted arylalkyl. 18. The compound of claim 17 , or a salt thereof, wherein G is CONH 2 or CO 2 R 1 and R 1 is C1-C6 alkyl. 19. The compound of claim 17 , having the Formula (3-A): or a salt thereof, or having the Formula (3-BA1): or a salt thereof. 20. The compound of claim 17 , having the Formula (3-A): or a salt thereof.

Assignees

Inventors

Classifications

  • Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

  • C07D403/04Primary

    directly linked by a ring-member-to-ring-member bond · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10556887B2 cover?
The present invention provides processes for the preparation of Veliparib (1), as well as intermediates useful in the preparation thereof. In particular, processes are provided for the production of the compound of Formula (3), or a salt thereof, and cyclization to afford Veliparib (1).
Who is the assignee on this patent?
Apotex Inc
What technology area does this patent fall under?
Primary CPC classification C07D403/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).